Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Top highlights include: the effects of COVID-19 on emergency visits, long-term symptoms and complications of COVID-19, safe outdoor activities during the pandemic, and a phase 3 clinical trial of COVID-19 vaccine is underway.
Many laboratory directors come from a technical background, however as healthcare becomes increasingly more complex, it is important to also have a strong financial foundation. An effective outreach leader will be able to consistently quantify revenue, cost and profitability of the outreach program, and communicate relevant data to senior leaders.
Dr. Morice was recently featured in The Athletic regarding sports teams and how to safely and efficiently bring them back.
This week’s research roundup features a study on atherosclerotic cardiovascular disease risk stratification based on measurements of troponin and coronary artery calcium.
The following list includes updates posted to mayocliniclabs.com during the month of July
Top highlights include: Mayo Clinic expert discusses what it will take to reduce widespread transmission, herd immunity discussion with Dr. Bill Morice, skin care tips, and COVID-19 back-to-school checklist.
In the last decade or so, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays. This incredible technology has facilitated the rapid and high-throughput evaluation of many genes (hundreds of thousands of DNA strands) all at once.
This week’s research roundup features a study the exploration of the transcriptomic differences between patients with hypertrophic cardiomyopathy (HCM) and controls.
Top highlights include: test pooling and precautions from Dr. Bill Morice, radiology technologists uses slow times to train to help with department's AI projects, and a COVID-19 update with Dr. Greg Poland.
This week’s research roundup features a study on cardiac troponin for the diagnosis and risk-stratification of myocardial injury in patients with COVID-19.
Top highlights include: how to understand contact tracing, supply chain management during COVID-19, infections of the virus in children, and the benefits of wearing a mask.
In June 2020, Mayo Clinic Laboratories announced three new tests along with numerous reference value changes, obsolete tests, and algorithm changes.